Hong Wei Chu Selected Research

Mycoplasma Pneumonia

1/2020	A 20-Mer Peptide Derived from the Lectin Domain of SP-A2 Decreases Tumor Necrosis Factor Alpha Production during Mycoplasma pneumoniae Infection.
8/2009	Impact of cigarette smoke exposure on innate immunity: a Caenorhabditis elegans model.
11/2008	Cigarette smoke decreases MARCO expression in macrophages: implication in Mycoplasma pneumoniae infection.
10/2008	Mycoplasma pneumoniae infection and environmental tobacco smoke inhibit lung glutathione adaptive responses and increase oxidative stress.
5/2007	A deficient TLR2 signaling promotes airway mucin production in Mycoplasma pneumoniae-infected allergic mice.
1/2007	IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection.
7/2005	Mycoplasma pneumoniae infection increases airway collagen deposition in a murine model of allergic airway inflammation.
3/2003	Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hong Wei Chu Research Topics

Disease

40	Inflammation (Inflammations) 06/2022 - 04/2002
39	Infections 06/2022 - 03/2003
28	Asthma (Bronchial Asthma) 06/2022 - 04/2002
16	Chronic Obstructive Pulmonary Disease (COPD) 01/2018 - 05/2005
11	Pneumonia (Pneumonitis) 06/2022 - 07/2002
9	Virus Diseases (Viral Diseases) 06/2022 - 01/2010
9	Bacterial Infections (Bacterial Infection) 01/2017 - 05/2007
8	Lung Diseases (Lung Disease) 01/2022 - 05/2005
8	Mycoplasma Pneumonia 01/2020 - 03/2003
5	Respiratory Hypersensitivity 12/2021 - 10/2010
4	Acute Lung Injury 04/2022 - 12/2004
4	Neoplasms (Cancer) 01/2022 - 03/2013
3	Lung Injury 10/2017 - 01/2011
3	Emphysema 01/2016 - 01/2011
3	Wounds and Injuries (Trauma) 10/2013 - 10/2002
3	Mycoplasma Infections 09/2007 - 03/2003
2	Human Influenza (Influenza) 01/2022 - 01/2020
2	Airway Obstruction (Choking) 01/2020 - 05/2005
2	Fibrosis (Cirrhosis) 01/2018 - 07/2005
2	Necrosis 10/2017 - 01/2011
2	Respiratory Syncytial Virus Infections 01/2013 - 01/2010
2	Respiratory Tract Infections (Respiratory Tract Infection) 05/2007 - 05/2005
2	Airway Remodeling 07/2005 - 03/2005
1	Body Weight (Weight, Body) 06/2022
1	Chronic Bronchitis 01/2022
1	Bronchitis 01/2022
1	COVID-19 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020

Drug/Important Bio-Agent (IBA)

18	CytokinesIBA 06/2022 - 03/2003
17	SmokeIBA 01/2022 - 03/2006
16	Proteins (Proteins, Gene)FDA Link 06/2022 - 03/2003
12	Interleukin-13IBA 01/2022 - 10/2002
7	Interleukin-33IBA 06/2022 - 01/2017
7	Interleukin-8 (Interleukin 8)IBA 01/2022 - 01/2013
5	MucinsIBA 01/2022 - 10/2004
5	Messenger RNA (mRNA)IBA 01/2016 - 01/2007
5	Toll-Like Receptor 2IBA 01/2012 - 04/2008
4	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2018
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 04/2002
4	OvalbuminIBA 08/2012 - 03/2003
3	ChemokinesIBA 06/2022 - 12/2004
3	Interleukin-4 (Interleukin 4)IBA 01/2022 - 03/2003
3	Biological ProductsIBA 12/2021 - 01/2005
3	Pulmonary Surfactants (Pulmonary Surfactant)IBA 01/2020 - 01/2010
3	Phospholipids (Phosphatides)FDA LinkGeneric 01/2020 - 01/2010
3	AntioxidantsIBA 01/2017 - 01/2011
3	Therapeutic UsesIBA 01/2016 - 11/2013
3	Interleukin-6 (Interleukin 6)IBA 01/2016 - 04/2008
3	Glutathione (Reduced Glutathione)IBA 10/2015 - 10/2008
3	Fluticasone (Cutivate)FDA LinkGeneric 10/2010 - 03/2003
3	AllergensIBA 05/2007 - 03/2003
3	CollagenIBA 07/2005 - 06/2003
3	Transforming Growth Factor beta (TGF-beta)IBA 01/2005 - 06/2003
2	Pattern Recognition ReceptorsIBA 04/2022 - 03/2005
2	Toll-Like Receptor 4IBA 04/2022 - 03/2005
2	Particulate MatterIBA 12/2021 - 10/2020
2	EnzymesIBA 01/2021 - 01/2011
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2020
2	PhosphatidylglycerolsIBA 01/2020 - 01/2010
2	Nicotine FDA Link 01/2020 - 01/2014
2	A-factor (Streptomyces)IBA 01/2020 - 03/2006
2	Chemokine CCL24IBA 01/2018 - 08/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2017 - 01/2016
2	Interleukin-1 Receptor-Associated KinasesIBA 01/2017 - 11/2013
2	Bovine Serum AlbuminIBA 12/2016 - 01/2016
2	LigandsIBA 01/2016 - 04/2008
2	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2016 - 05/2013
2	Leukocyte Elastase (Neutrophil Elastase)IBA 11/2013 - 01/2013
2	Nitric Oxide Synthase (NO Synthase)IBA 11/2010 - 07/2002
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2010 - 03/2004
2	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2005 - 10/2004
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 07/2005 - 10/2002
2	LipopolysaccharidesIBA 03/2005 - 12/2004
2	Protein Isoforms (Isoforms)IBA 01/2005 - 07/2002
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2003 - 01/2003
1	Apyrase (ATP Diphosphatase)IBA 06/2022
1	Adenosine Triphosphate (ATP)IBA 06/2022
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	Dehydroepiandrosterone (DHEA)IBA 01/2022
1	AndrogensIBA 01/2022
1	Interleukin-5 (Interleukin 5)IBA 01/2022
1	E-Cigarette VaporIBA 01/2022
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021
1	Integrin alpha4beta1 (VLA-4)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020
1	LectinsIBA 01/2020
1	Mitochondrial DNA (mtDNA)IBA 01/2020
1	LipidsIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2019
1	LactoferrinIBA 01/2019
1	Chemokine CCL26IBA 05/2018
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 01/2018
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2018

Therapy/Procedure

5	Therapeutics 01/2019 - 05/2010
1	Immunotherapy 01/2020